Preventives/remedies for proliferative organ diseases chronic arthritic diseases, hypertrophic scar or keloid
Patent Number: 7053050
Date of First Priority Issue: Sunday February 11th, 2001
Date Issued: Tuesday May 30th, 2006
Assignee: Yoshiko Yasuda (Kyoto, JP)
Inventors: Yasuda, Yoshiko (Kyoto, JP); Nakamura, Yukio (Higashimurayama, JP); Fujita, Yoshihiko (Sakai, JP)
From Class: Expansion
Comments: No comments
This patent is useful for treatment of proliferative diseases, including cancer. It is known that erythropoietin has functions on numerous stem cells in addition to hematopoietic ones. In this patent the inventors demonstrated that inhibition of EPO receptor signalling can have a useful anti-proliferative effect. The 2 independent claims cover use of the receptor antagonist and use of the receptor antagonist combined with an anticancer agent for treatment of proliferative diseases.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.